Here, Faltas and colleagues report its distinctive molecular and immune landscape compared to urothelial carcinoma of the bladder and explore the role of FGFR3 signaling in UTUC biology. This evidence concerns the gene FGFR3 and renal pelvis/ureter urothelial carcinoma.